Sutro Biopharma Showcases ADC Platform at 16th Annual World ADC London Summit

Sutro Biopharma presented its latest developments in antibody-drug conjugate technology at the 16th Annual World ADC London Summit. The presentation highlights the company's proprietary platform and its role in the evolving oncology treatment landscape.

Emma Taylor

February 28, 2026132 views

Related Stories

Finance

Netflix Abandons Warner Bros. Acquisition: Analyzing the Strategic Shift in Media Consolidation

18m ago

Finance

Citizens Financial Group Shares Plunge 7.8% as Inflation Data Ignites Regional Banking Credit Concerns

40m ago

Finance

TORM plc Reports Q4 2025 Results as Geopolitical Volatility Reshapes Global Shipping Routes

1h ago

Finance

Novavax Unveils Fourth Quarter 2025 Financial Results as Biotech Sector Faces Macroeconomic Pressures

1h ago

Comments (2)

Sign in to leave a comment.

Emeka Okafor2h ago

The potential of these '

00

Reply

Megan Foster2h ago

The evolution of AD

00

Reply